Fresenius Medical Care AG (FME.DE), a provider of products and services for individuals with renal diseases, on Tuesday announced a new share buyback program of about EUR 1 billion.
The company said the program will be carried out in tranches over 12 months and is expected to begin in the near future. Its previous EUR 1 billion share buyback program was completed on April 30, 2026.
"Launching a new share buyback program shortly after successfully completing our initial EUR 1 billion share buyback - ahead of schedule - demonstrates our financial strength and disciplined execution. This new program underscores our confidence in our FME Reignite strategy, our performance, and the future sustainable profitable growth trajectory of Fresenius Medical Care," said Helen Giza, CEO and Chair of the Management Board of Fresenius.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.